Accompanying the EPILAB startup incubated by École Polytechnique
Context and need
EpiLAB designs and develops a disruptive portable tuberculosis screening test technology In fact, the offer of EpilAB compared to its screening kit is intended to be portable, easy to use, inexpensive and sensitive.
Accompany the development of the project throughout the incubation to the end-of-program investor pitch
- Validation by the MedTech ecosystem and screening of the 3 million undetected patients ongoing
- A coherent technical and financial strategic roadmap
- Subsidies being obtained